Actions of ergometrine on catecholamine receptors in the guinea-pig vas deferens and in the snail brain.
D000200:Action Potentials / Q000187:drug effects; D000818:Animals; D001921:Brain / Q000187:drug effects*; D002395:Catecholamines; D004298:Dopamine / Q000008:administration & dosage / Q000494:pharmacology; D018492:Dopamine Antagonists; D004305:Dose-Response Relationship, Drug; D004357:Drug Synergism; D004874:Ergonovine / Q000494:pharmacology*; D006168:Guinea Pigs; D006220:Haloperidol / Q000494:pharmacology; D066298:In Vitro Techniques; D007478:Iontophoresis; D008297:Male; D009474:Neurons / Q000187:drug effects; D009638:Norepinephrine / Q000008:administration & dosage / Q000037:antagonists & inhibitors / Q000494:pharmacology; D011955:Receptors, Drug / Q000187:drug effects*; D012908:Snails; D013045:Species Specificity; D014649:Vas Deferens / Q000187:drug effects*
D002395:Catecholamines; D018492:Dopamine Antagonists; D011955:Receptors, Drug; D006220:Haloperidol; D004298:Dopamine; D004874:Ergonovine; D009638:Norepinephrine